NuGen Medical Devices Inc (NGMD) — Strategic Asset Allocation Index
NuGen Medical Devices Inc (NGMD) has a Strategic Asset Allocation Index of 1.9% as of March 2022. Strategic assets (PP&E of CA$14.02K plus long-term investments of CA$-) total CA$14.02K, measured against net assets of CA$756.09K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See NGMD net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Annual Strategic Asset Allocation Index for NuGen Medical Devices Inc (None–None)
The table below presents the year-by-year Strategic Asset Allocation Index for NuGen Medical Devices Inc from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See NGMD net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|